QUOTE AND NEWS
FiercePharma  Sep 4  Comment 
Pharma's summer TV advertising ended with the same old story for the most part, but a new drug on the top-10 list might be taking the place of one of its siblings.
MedPage Today  Aug 28  Comment 
(MedPage Today) -- Established for in-stent restenosis, DCBs make their way to native coronary arteries
FierceBiotech  Aug 23  Comment 
Novo Nordisk has signed another deal intended to keep it at the top of the tree when it comes to developing new diabetes and obesity drugs.
FiercePharma  Aug 20  Comment 
The approval case for Novo Nordisk’s oral GLP-1 diabetes candidate keeps on building, this time with new data in patients with kidney troubles, a common affliction among people with the disease.





You may also be interested in articles related to Novo Nordisk A/S (NVO):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki